Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
88.26
+0.01 (0.01%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Edwards Lifesciences stock has a consensus rating of "Buy" and an average price target of $100.96. The average 1-year stock price forecast is 14.39% higher than the current stock price, while the lowest is $84 (-4.83%) and the highest is $110 (+24.63%).
Price Target: $100.96 (+14.39%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 18 | 18 | 18 |
| Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Hold | 8 | 8 | 8 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 30 | 29 | 29 | 29 | 29 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $105 | Buy | Maintains | $105 | +18.97% | Sep 11, 2026 |
| BTIG | BTIG | Buy Maintains $110 | Buy | Maintains | $110 | +24.63% | Sep 11, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 10, 2026 |
| Citi | Citi | Buy Maintains $110 | Buy | Maintains | $110 | +24.63% | Sep 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $85 | Hold | Maintains | $85 | -3.69% | Aug 4, 2026 |
Financial Forecast
Revenue This Year
6.76B
from 6.07B
Increased by 11.40%
Revenue Next Year
7.43B
from 6.76B
Increased by 9.90%
EPS This Year
3.00
from 2.56
Increased by 17.17%
EPS Next Year
3.38
from 3.00
Increased by 12.59%
EPS and Forward PE are based on non-GAAP adjusted numbers.